Second, this study has a lack of data about gut hormones such as GIP, GLP-1, PYY, and ghrelin, all of which also play an important role in the change of diabetic status and MS in patients who have undergone bariatric surgery. The gene discussed is GCG; the disease is myeloid sarcoma.